Dual modification of Alzheimer’s disease PHF-tau protein by lysine methylation and ubiquitylation: a mass spectrometry approach

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1× · see citing works

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · see citing works

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172 · see citing works

Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859 · see citing works

A Model for Random Sampling and Estimation of Relative Protein Abundance in Shotgun Proteomics

Liu, H., Sadygov, R. G., & Yates, J. R. (2004) · Analytical Chemistry · doi:10.1021/ac0498563 · Cited by 2,486 · see citing works

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work.

Buée, L., Bussière, T., Buée‐Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,007 · see citing works

Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease

Gómez-Isla, T., Price, J. L., McKeel Jr., D. W., Morris, J. C., Growdon, J. H., & Hyman, B. T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04491.1996 · Cited by 1,796 · cited 1× · see citing works

Large-scale characterization of HeLa cell nuclear phosphoproteins

Beausoleil, S. A., Jedrychowski, M. P., Schwartz, D., Elias, J. E., Villén, J., Li, J., Cohn, M. A., Cantley, L. C., & Gygi, S. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404720101 · Cited by 1,376 · see citing works

Comparison of Label-free Methods for Quantifying Human Proteins by Shotgun Proteomics

Old, W. M., Meyer-Arendt, K., Aveline-Wolf, L. D., Pierce, K. G., Mendoza, A. M., Sevinsky, J. R., Resing, K. A., & Ahn, N. G. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500084-mcp200 · Cited by 1,206 · see citing works

Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease

Giannakopoulos, P., Herrmann, F. R., Bussière, T., Bouras, C., Kövari, E., Perl, D. P., Morrison, J. H., Gold, G., & Hof, P. R. (2003) · Neurology · doi:10.1212/01.wnl.0000063311.58879.01 · Cited by 1,118 · see citing works

Cloning and sequencing of the cDNA encoding an isoform of microtubule‐associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain.

Goedert, M., Spillantini, M. G., Potier, M. C., Ulrich, J., & Crowther, R. A. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03390.x · Cited by 1,037 · see citing works

Assembly of τ protein into Alzheimer paired helical filaments depends on a local sequence motif ( ³⁰⁶ VQIVYK ³¹¹ ) forming β structure

von Bergen, M., Friedhoff, P., Biernat, J., Heberle, J., Mandelkow, E.-M., & Mandelkow, E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5129 · Cited by 1,021 · see citing works

Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease

Augustinack, J. C., Schneider, A., Mandelkow, E.-M., & Hyman, B. T. (2002) · Acta Neuropathologica · doi:10.1007/s004010100423 · Cited by 998 · see citing works

Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments

Alonso, A. D. C., Zaidi, T., Novák, M., Grundke, I., & Iqbal, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121119298 · Cited by 968 · see citing works

Tau phosphorylation: the therapeutic challenge for neurodegenerative disease

Hanger, D. P., Anderton, B. H., & Noble, W. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.01.003 · Cited by 965 · see citing works

Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy

Min, S.-W., Cho, S.-H., Zhou, Y., Schroeder, S., Haroutunian, V., Seeley, W. W., Huang, E. J., Shen, Y., Masliah, E., Mukherjee, C., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.044 · Cited by 949 · see citing works

Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding

Bramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903 · see citing works

Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding

Biernat, J., Gustke, N., Drewes, G., Mandelkow, E., & Mandelkow, E. (1993) · Neuron · doi:10.1016/0896-6273(93)90279-z · Cited by 796 · see citing works

O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's disease

Liu, F., Iqbal, K., Grundke-Iqbal, I., Hart, G. W., & Gong, C.-X. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400348101 · Cited by 775 · see citing works

CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation

Petrucelli, L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh083 · Cited by 735 · cited 1× · see citing works

The acetylation of tau inhibits its function and promotes pathological tau aggregation

Cohen, T. J., Guo, J. L., Hurtado, D. E., Kwong, L. K., Mills, I. P., Trojanowski, J. Q., & Lee, V. M. Y. (2011) · Nature Communications · doi:10.1038/ncomms1255 · Cited by 724 · see citing works

Reduction of Lipofuscin-like Autofluorescence in Fluorescently Labeled Tissue

Schnell, S. A., Staines, W. A., & Wessendorf, M. W. (1999) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549904700601 · Cited by 691 · see citing works

Post-translational modifications of tau protein: Implications for Alzheimer's disease

Martin, L., Latypova, X., & Terro, F. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2010.12.023 · Cited by 645 · see citing works

Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205

Goedert, M., Jakes, R., & Vanmechelen, E. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11484-e · Cited by 608 · see citing works

Phosphorylation that Detaches Tau Protein from Microtubules (Ser262, Ser214) Also Protects It against Aggregation into Alzheimer Paired Helical Filaments

Schneider, A., Biernat, J., von Bergen, M., Mandelkow, E., & Mandelkow, E.-M. (1999) · Biochemistry · doi:10.1021/bi981874p · Cited by 564 · see citing works

CHIP-Hsc70 Complex Ubiquitinates Phosphorylated Tau and Enhances Cell Survival

Shimura, H., Schwartz, D., Gygi, S. P., & Kosik, K. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305838200 · Cited by 469 · see citing works

Tau interacts with src-family non-receptor tyrosine kinases

Lee, G. S., Newman, S. T., Gard, D. L., Band, H., & Panchamoorthy, G. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.21.3167 · Cited by 445 · see citing works

Cross-regulation of histone modifications

Latham, J. A., & Dent, S. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1307 · Cited by 406 · see citing works

Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament

Novak, M., Kabat, J., & Wischik, C. M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05665.x · Cited by 398 · see citing works

Detecting Differential and Correlated Protein Expression in Label-Free Shotgun Proteomics

Zhang, B., VerBerkmoes, N. C., Langston, M. A., Uberbacher, E. C., Hettich, R. L., & Samatova, N. F. (2006) · Journal of Proteome Research · doi:10.1021/pr0600273 · Cited by 394 · see citing works

Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes.

LoPresti, P., Szuchet, S., Papasozomenos, S. C., Zinkowski, R. P., & Binder, L. I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10369 · Cited by 388 · see citing works

New Phosphorylation Sites Identified in Hyperphosphorylated Tau (Paired Helical Filament‐Tau) from Alzheimer's Disease Brain Using Nanoelectrospray Mass Spectrometry

Hanger, D. P., Betts, J. C., Loviny, T. L. F., Blackstock, W. P., & Anderton, B. H. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71062465.x · Cited by 378 · see citing works

Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein

Goedert, M., Jakes, R., Crowther, R. A., Cohen, P., Vanmechelen, E., Vandermeeren, M., & Cras, P. (1994) · Biochemical Journal · doi:10.1042/bj3010871 · Cited by 375 · see citing works

Significance Analysis of Spectral Count Data in Label-free Shotgun Proteomics

Choi, H., Fermin, D., & Nesvizhskii, A. I. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800203-mcp200 · Cited by 364 · see citing works

Alzheimer Disease-specific Conformation of Hyperphosphorylated Paired Helical Filament-Tau Is Polyubiquitinated through Lys-48, Lys-11, and Lys-6 Ubiquitin Conjugation

Cripps, D., Thomas, S. N., Jeng, Y., Yang, F., Davies, P., & Yang, A. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512786200 · Cited by 312 · see citing works

Meta-analysis of multiple outcomes by regression with random effects

Berkey, C. S., Hoaglin, D. C., Antczak‐Bouckoms, A., Mosteller, F. C., & Colditz, G. A. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19981130)17:22 · Cited by 274 · see citing works

The Generation of a 17 kDa Neurotoxic Fragment: An Alternative Mechanism by which Tau Mediates β-Amyloid-Induced Neurodegeneration

Park, S.-Y., & Ferreira, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1125-05.2005 · Cited by 262 · see citing works

Phosphorylation Regulates Tau Interactions with Src Homology 3 Domains of Phosphatidylinositol 3-Kinase, Phospholipase Cγ1, Grb2, and Src Family Kinases

Reynolds, C. H., Garwood, C. J., Wray, S., Price, C., Kellie, S., Perera, T. P. S., Zvelebil, M., Yang, A., Sheppard, P. W., Varndell, I. M., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709715200 · Cited by 226 · see citing works

Probabilistic assembly of human protein interaction networks from label-free quantitative proteomics

Sardiu, M. E., Cai, Y., Jin, J., Swanson, S. K., Conaway, R. C., Conaway, J. W., Florens, L., & Washburn, M. P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706983105 · Cited by 226 · see citing works

Akt and CHIP coregulate tau degradation through coordinated interactions

Dickey, C. A., Koren, J., Zhang, Y.-J., Xu, Y.-F., Jinwal, U. K., Birnbaum, M. J., Monks, B., Sun, M., Cheng, J. Q., Patterson, C., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709180105 · Cited by 226 · see citing works

β‐amyloid burden is not associated with rates of brain atrophy

Josephs, K. A., Whitwell, J. L., Ahmed, Z., Shiung, M. M., Weigand, S. D., Knopman, D. S., Boeve, B. F., Parisi, J. E., Petersen, R. C., Dickson, D. W., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21223 · Cited by 224 · see citing works

Characterization of Two VQIXXK Motifs for Tau Fibrillization in Vitro

Li, W., & Lee, V. M. ‐. (2006) · Biochemistry · doi:10.1021/bi061422+ · Cited by 197 · see citing works

Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease

Ghoshal, N. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.8014 · Cited by 192 · see citing works

Tyrosine 394 Is Phosphorylated in Alzheimer's Paired Helical Filament Tau and in Fetal Tau with c-Abl as the Candidate Tyrosine Kinase

Derkinderen, P., Scales, T. M. E., Hanger, D. P., Leung, K., Byers, H. L., Ward, M. A., Lenz, C., Price, C., Bird, I. N., Perera, T. P. S., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1487-05.2005 · Cited by 186 · see citing works

Influence of Combinatorial Histone Modifications on Antibody and Effector Protein Recognition

Fuchs, S. M., Krajewski, K., Baker, R. W., Miller, V. L., & Strahl, B. D. (2010) · Current Biology · doi:10.1016/j.cub.2010.11.058 · Cited by 182 · see citing works

The proline-rich domain of tau plays a role in interactions with actin

He, H. J., Wang, X. S., Pan, R., Wang, D. L., Liu, M. N., & He, R. Q. (2009) · BMC Cell Biology · doi:10.1186/1471-2121-10-81 · Cited by 142 · see citing works

Pseudophosphorylation and Glycation of Tau Protein Enhance but Do Not Trigger Fibrillization in Vitro

Necula, M., & Kuret, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405527200 · Cited by 136 · see citing works

Conversion of Serine to Aspartate Imitates Phosphorylation-induced Changes in the Structure and Function of Microtubule-associated Protein Tau

Léger, J. G., Kempf, M., Lee, G. S., & Brandt, R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8441 · Cited by 131 · see citing works

Nucleation-dependent Tau Filament Formation

Congdon, E. E., Kim, S., Bonchak, J., Songrug, T., Anastasios Matzavinos, A., & Kuret, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800247200 · Cited by 126 · see citing works

Granulovacuolar degeneration (GVD) bodies of Alzheimer's disease (AD) resemble late-stage autophagic organelles

Funk, K. E., Mrak, R. E., & Kuret, J. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01135.x · Cited by 123 · see citing works

Comparative proteomic and transcriptomic profiling of the fission yeast Schizosaccharomyces pombe

Schmidt, M. W., Houseman, A., Ivanov, A. R., & Wolf, D. A. (2007) · Molecular Systems Biology · doi:10.1038/msb4100117 · Cited by 114 · see citing works

Tau Phosphorylated at Tyrosine 394 is Found in Alzheimer's Disease Tangles and can be a Product of the Abl-Related Kinase, Arg

Tremblay, M. A., Acker, C. M., & Davies, P. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1271 · Cited by 106 · see citing works

Large-scale evaluation of protein reductive methylation for improving protein crystallization

Kim, Y., Quartey, P., Li, H., Volkart, L., Hatzos, C., Chang, C., Nocek, B. P., Cuff, M. E., Osipiuk, J., Tan, K., et al. (2008) · Nature Methods · doi:10.1038/nmeth1008-853 · Cited by 90 · see citing works

Complications in the Assignment of 14 and 28 Da Mass Shift Detected by Mass Spectrometry as in Vivo Methylation from Endogenous Proteins

Jung, S. Y., Li, Y., Wang, Y., Chen, Y., Zhao, Y., & Qin, J. (2008) · Analytical Chemistry · doi:10.1021/ac7021025 · Cited by 74 · see citing works

Pathological Determinants of the Transition to Clinical Dementia in Alzheimer's Disease

Royall, D. R., Palmer, R. F., Mulroy, A. R., Polk, M. J., Román, G. C., David, J. P., & Delacourte, A. (2002) · Experimental Aging Research · doi:10.1080/03610730252800166 · Cited by 70 · see citing works

Casein kinase-1 isoforms differentially associate with neurofibrillary and granulovacuolar degeneration lesions

Kannanayakal, T. J., Tao, H., Vandré, D. D., & Kuret, J. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0049-9 · Cited by 59 · see citing works

X‐34 Labeling of Abnormal Protein Aggregates During the Progression of Alzheimer's Disease

Ikonomović, M. D., Abrahamson, E. E., Isanski, B. A., Debnath, M. L., Mathis, C. A., DeKosky, S. T., & Klunk, W. E. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)12009-1 · Cited by 58 · see citing works

Abnormal tau proteins from Alzheimer's disease brains. Purification and amino acid analysis.

Liu, W. K., Ksiȩżak-Reding, H., & Yen, S. H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54696-2 · Cited by 52 · see citing works

Pseudophosphorylation of tau protein directly modulates its aggregation kinetics

Chang, E., Kim, S., Schafer, K. N., & Kuret, J. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.10.005 · Cited by 39 · see citing works

Removal of Pattern-breaking Sequences in Microtubule Binding Repeats Produces Instantaneous Tau Aggregation and Toxicity

Iliev, A. I., Ganesan, S., Bunt, G., & Wouters, F. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604863200 · Cited by 31 · see citing works

O-GlcNAc Modification and the Tauopathies: Insights from Chemical Biology

Yuzwa, S. A., & Vocadlo, D. J. (2009) · Current Alzheimer Research · doi:10.2174/156720509789207967 · Cited by 28 · see citing works

Mapping of Lysine Monomethylation of Linker Histones in Human Breast and Its Cancer

Lu, A., Zougman, A., Pudełko, M., Bębenek, M., Ziolkowski, P. P., Mann, M., & Wiśniewski, J. R. (2009) · Journal of Proteome Research · doi:10.1021/pr9000652 · Cited by 28 · see citing works

New surface contacts formed upon reductive lysine methylation: Improving the probability of protein crystallization

Sledz, P., Zheng, H., Murzyn, K., Chruszcz, M., Zimmerman, M. D., Chordia, M. D., Joachimiak, A., & Minor, W. (2010) · Protein Science · doi:10.1002/pro.420 · Cited by 27 · see citing works

Modification of Amino Groups

Geoghegan, K. F. (1996) · Current Protocols in Protein Science · doi:10.1002/0471140864.ps1502s04 · Cited by 12 · see citing works

Detection and Reduction of Neurofibrillary Lesions

Kuret, J. (2007) · Enzyme inhibitors series/CRC enzyme inhibitors series · doi:10.1201/9781420007145.ch6 · Cited by 6 · see citing works

Correlation between tau phosphorylation sites and tangle morphology in Alzheimer's disease

Shimazaki, M., NAKANO, H., & Kobayashi, K. (2005) · Psychogeriatrics · doi:10.1111/j.1479-8301.2005.00087.x · Cited by 2 · see citing works

Untitled work

(1997) · doi:10.1002/(sici)1097-4547(19970415)48:2

Artificial intelligence to deep learning: machine intelligence approach for drug discovery

Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473 · see citing works

Neuronal Cell Death

Fricker, M., Tolkovsky, A. M., Borutaitė, V., Coleman, M. P., & Brown, G. C. (2018) · Physiological Reviews · doi:10.1152/physrev.00011.2017 · Cited by 1,122 · see citing works

Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease

Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994 · see citing works

Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice

Morris, M., Knudsen, G. M., Maeda, S., Trinidad, J. C., Ioanoviciu, A., Burlingame, A. L., & Mucke, L. (2015) · Nature Neuroscience · doi:10.1038/nn.4067 · Cited by 472 · see citing works

Glial contributions to neurodegeneration in tauopathies

Leyns, C. E. G., & Holtzman, D. M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0192-x · Cited by 409 · see citing works

Alzheimer’s disease: insights into pathology, molecular mechanisms, and therapy

Zheng, Q., & Wang, X. (2024) · Protein & Cell · doi:10.1093/procel/pwae026 · Cited by 454 · see citing works

What is the evidence that tau pathology spreads through prion-like propagation?

Mudher, A., Colin, M., Dujardin, S., Medina, M., Dewachter, I., Alavi Naini, S. M., Mandelkow, E.-M., Mandelkow, E., Buée, L., Goedert, M., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0488-7 · Cited by 384 · see citing works

Amyloid-β and tau complexity — towards improved biomarkers and targeted therapies

Polanco, J. C., Li, C., Bodea, L., Martínez‐Mármol, R., Meunier, F. A., & Götz, J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.162 · Cited by 374 · see citing works

Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics

Ali, I., Conrad, R. J., Verdin, E. M., & Ott, M. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00181 · Cited by 366 · see citing works

Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation

Alquezar, C., Arya, S., & Kao, A. W. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.595532 · Cited by 367 · see citing works

Dendritic Tau in Alzheimer’s Disease

Ittner, A., & Ittner, L. M. (2018) · Neuron · doi:10.1016/j.neuron.2018.06.003 · Cited by 278 · see citing works

Tau-based therapies in neurodegeneration: opportunities and challenges

Li, C., & Götz, J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.155 · Cited by 272 · see citing works

Neuroprotective Natural Products for Alzheimer’s Disease

Chen, X., Drew, J., Berney, W., & Lei, W. (2021) · Cells · doi:10.3390/cells10061309 · Cited by 236 · see citing works

Updates in Alzheimer's disease: from basic research to diagnosis and therapies

Liu, E., Zhang, Y., & Wang, J. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00432-x · Cited by 220 · see citing works

It’s all about tau

Tapia‐Rojas, C., Cabezas-Opazo, F., Deaton, C. A., Vergara, E. H., Johnson, G. V. W., & Quintanilla, R. A. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.12.005 · Cited by 195 · see citing works

Tau prions from Alzheimer’s disease and chronic traumatic encephalopathy patients propagate in cultured cells

Woerman, A. L., Aoyagi, A., Patel, S. S., Kazmi, S. A., Lobach, I. V., Grinberg, L. T., McKee, A. C., Seeley, W. W., Olson, S. H., & Prusiner, S. B. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616344113 · Cited by 174 · see citing works

Degradation of tau protein by autophagy and proteasomal pathways

Wang, Y., & Mandelkow, E. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120071 · Cited by 166 · see citing works

Amyloidogenesis of Tau protein

Niżyński, B., Dzwolak, W., & Nieznański, K. (2017) · Protein Science · doi:10.1002/pro.3275 · Cited by 157 · see citing works

Tau Phosphorylation Rates Measured by Mass Spectrometry Differ in the Intracellular Brain vs. Extracellular Cerebrospinal Fluid Compartments and Are Differentially Affected by Alzheimer’s Disease

Barthélemy, N. R., Mallipeddi, N., Moiseyev, P., Sato, C., & Bateman, R. J. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00121 · Cited by 152 · see citing works

Lysine methylation is an endogenous post-translational modification of tau protein in human brain and a modulator of aggregation propensity

Funk, K. E., Thomas, S. N., Schafer, K. N., Cooper, G. L., Liao, Z., Clark, D. J., Yang, A. J., & Kuret, J. (2014) · Biochemical Journal · doi:10.1042/bj20140372 · Cited by 142 · see citing works

FLEXITau: Quantifying Post-translational Modifications of Tau Protein in Vitro and in Human Disease

Mair, W., Muntel, J., Tepper, K., Tang, S., Biernat, J., Seeley, W. W., Kosik, K. S., Mandelkow�, E., Steen, H., & Steen, J. A. J. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b04509 · Cited by 144 · see citing works

Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer’s disease from a ferroptosis perspective

Derry, P. J., Hegde, M. L., Jackson, G. R., Kayed, R., Tour, J. M., Tsai, A.-L., & Kent, T. A. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101716 · Cited by 142 · see citing works

X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women

Yan, Y., Wang, X., Chaput, D., Shin, M.-K., Koh, Y., Gan, L., Pieper, A. A., Woo, J.-A. A., & Kang, D. E. (2022) · Cell · doi:10.1016/j.cell.2022.09.002 · Cited by 144 · see citing works

Lysine-Directed Post-translational Modifications of Tau Protein in Alzheimer's Disease and Related Tauopathies

Kontaxi, C., Piccardo, P., & Gill, A. C. (2017) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2017.00056 · Cited by 138 · see citing works

Post-translational modifications: Regulators of neurodegenerative proteinopathies

Gupta, R. V., Sahu, M., Srivastava, D., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101336 · Cited by 124 · see citing works

Complex regulatory mechanisms mediated by the interplay of multiple post-translational modifications

Csizmók, V., & Forman-Kay, J. D. (2017) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2017.10.013 · Cited by 123 · see citing works

Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity

Barthélemy, N. R., Fenaille, F., Hirtz, C., Sergeant, N., Schraen-Maschke, S., Vialaret, J., Buée, L., Gabelle, A., Junot, C., Lehmann, S., et al. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b01001 · Cited by 123 · see citing works

Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease

Balmik, A. A., & Chinnathambi, S. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00732-z · Cited by 108 · see citing works

Glucose metabolism and AD: evidence for a potential diabetes type 3

González, A., Calfío, C., Churruca, M., & Maccioni, R. B. (2022) · Alzheimer's Research & Therapy · doi:10.1186/s13195-022-00996-8 · Cited by 112 · see citing works

Structure and Mechanism of Action of Tau Aggregation Inhibitors

Cisek, K. K., Cooper, G., Huseby, C. J., & Kuret, J. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666141107150331 · Cited by 98 · see citing works

Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies

Zhang, X., Wang, J., Zhang, Z., & Ye, K. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00429-6 · Cited by 106 · see citing works

Small molecule therapeutics for tauopathy in Alzheimer’s disease: Walking on the path of most resistance

Wang, L., Bharti, Kumar, R., Pavlov, P. F., & Winblad, B. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112915 · Cited by 92 · see citing works

Tau at the interface between neurodegeneration and neuroinflammation

Didonna, A. (2020) · Genes & Immunity · doi:10.1038/s41435-020-00113-5 · Cited by 82 · see citing works

Tau-induced neurodegeneration: mechanisms and targets

Beharry, C., Cohen, L. S., Di, J., Ibrahim, K., Briffa-Mirabella, S., & Alonso, A. D. C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1414-z · Cited by 88 · see citing works

Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease

Abreha, M. H., Dammer, E. B., Ping, L., Zhang, T., Duong, D. M., Gearing, M., Lah, J. J., Levey, A. I., & Seyfried, N. T. (2018) · PROTEOMICS · doi:10.1002/pmic.201800108 · Cited by 81 · see citing works

The Role of Post-Translational Modifications on the Structure and Function of Tau Protein

Ye, H., Han, Y., Li, P., Su, Z., & Huang, Y. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02002-0 · Cited by 74 · see citing works

Acetylated tau in Alzheimer's disease: An instigator of synaptic dysfunction underlying memory loss

Tracy, T. E., & Gan, L. (2017) · BioEssays · doi:10.1002/bies.201600224 · Cited by 72 · see citing works

Role of Post‐translational Modifications in Alzheimer's Disease

Ramesh, M., Gopinath, P., & Govindaraju, T. (2019) · ChemBioChem · doi:10.1002/cbic.201900573 · Cited by 68 · see citing works

Intracellular and Extracellular Roles for Tau in Neurodegenerative Disease

Hanger, D. P., Lau, D. H. W., Phillips, E. C., Bondulich, M. K., Guo, T., Woodward, B. W., Pooler, A. M., & Noble, W. J. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132054 · Cited by 62 · see citing works

Filamentous Aggregates Are Fragmented by the Proteasome Holoenzyme

Cliffe, R., Sang, J. C., Kundel, F., Finley, D. J., Klenerman, D., & Ye, Y. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.096 · Cited by 60 · see citing works

Protein aggregation and its affecting mechanisms in neurodegenerative diseases

Wu, J., Wu, J., Chen, T., Cai, J., & Ren, R. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105880 · Cited by 61 · see citing works

Quantification of Tau Protein Lysine Methylation in Aging and Alzheimer’s Disease

Huseby, C. J., Hoffman, C. N., Cooper, G. L., Cocuron, J.-C., Alonso, A. P., Thomas, S. N., Yang, A. J., & Kuret, J. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190604 · Cited by 54 · see citing works

The Role and Pathogenesis of Tau Protein in Alzheimer’s Disease

Hong, X.-Y., Huang, L., Lei, F., Li, T., Luo, Y., Zeng, M., & Wang, Z. (2025) · Biomolecules · doi:10.3390/biom15060824 · Cited by 52 · see citing works

Drug design targeting active posttranslational modification protein isoforms

Meng, F., Liang, Z. T., Zhao, K., & Luo, C. (2020) · Medicinal Research Reviews · doi:10.1002/med.21774 · Cited by 56 · see citing works

Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer’s disease

Annadurai, N., Agrawal, K., Džubák, P., Hajdúch, M., & Das, V. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2574-1 · Cited by 51 · see citing works

Disrupting Self-Assembly and Toxicity of Amyloidogenic Protein Oligomers by “ Molecular Tweezers” - from the Test Tube to Animal Models

Attar, A., & Bitan, G. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990496 · Cited by 48 · see citing works

Lysine methylation: Implications in neurodegenerative disease

Rowe, E. M., Xing, V., & Biggar, K. K. (2018) · Brain Research · doi:10.1016/j.brainres.2018.11.024 · Cited by 44 · see citing works

Cytoskeletal Proteins and Alzheimer’s Disease Pathogenesis: Focusing on the Interplay with Tau Pathology

Jiang, G., Xie, G., Li, X., & Xiong, J. (2025) · Biomolecules · doi:10.3390/biom15060831 · Cited by 45 · see citing works

Non-Histone Protein Methylation: Biological Significance and Bioengineering Potential

Blasi, R. D., Blyuss, O. B., Timms, J. F., Conole, D., Ceroni, F., & Whitwell, H. J. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.0c00771 · Cited by 44 · see citing works

Transcriptional signaling pathways inversely regulated in Alzheimer's disease and glioblastoma multiform

Liu, T., Ren, D., Zhu, X., Yin, Z., Jin, G., Zhao, Z., Robinson, D., Li, X., Wong, K., Cui, K., et al. (2013) · Scientific Reports · doi:10.1038/srep03467 · Cited by 42 · see citing works

Lysosomal Fusion Dysfunction as a Unifying Hypothesis for Alzheimer's Disease Pathology

Funk, K. E., & Kuret, J. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/752894 · Cited by 41 · see citing works

Neurochemical Profile of Dementia Pugilistica

Kokjohn, T. A., Maarouf, C. L., Daugs, I. D., Hunter, J. M., Whiteside, C. M., Malek-Ahmadi, M., Rodriguez, E., Kalback, W., Jacobson, S. A., Sabbagh, M. N., et al. (2013) · Journal of Neurotrauma · doi:10.1089/neu.2012.2699 · Cited by 39 · see citing works

The propagation mechanisms of extracellular tau in Alzheimer’s disease

Wei, Y., Liu, M., & Wang, D. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10573-y · Cited by 39 · see citing works

Single-cell spatial proteomic imaging for human neuropathology

Vijayaragavan, K., Cannon, B. J., Tebaykin, D., Bosse, M. M., Baranski, A., Oliveria, J. P., Bukhari, S. A., Mrdjen, D., Corces, M. R., McCaffrey, E., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01465-x · Cited by 37 · see citing works

The physiology and pathology of microtubule-associated protein tau

Wang, J., Gao, X., & Wang, Z.-H. (2014) · Essays in Biochemistry · doi:10.1042/bse0560111 · Cited by 35 · see citing works

Aggregation, Transmission, and Toxicity of the Microtubule-Associated Protein Tau: A Complex Comprehension

Hu, J., Sha, W., Yuan, S., Wu, J., & Huang, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241915023 · Cited by 35 · see citing works

SETD7-mediated monomethylation is enriched on soluble Tau in Alzheimer’s disease

Bichmann, M., Oriol, N. P., Ercan-Herbst, E., Schöndorf, D. C., Ramos, B. G., Schwärzler, V., Neu, M., Schlüter, A., Wang, X. B., Jin, L., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00468-x · Cited by 31 · see citing works

Therapeutic Strategies for Restoring Tau HomeostasisPreprint

Young, Z. T., Mok, S., & Gestwicki, J. E. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024612 · Cited by 29 · see citing works

Complicated Role of Post-translational Modification and Protease-Cleaved Fragments of Tau in Alzheimer’s Disease and Other Tauopathies

Yang, J., Shen, N., Shen, J., Yang, Y., & Li, H.-L. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03867-x · Cited by 32 · see citing works

Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology

Kalyaanamoorthy, S., Opare, S. K. A., Xu, X., Ganesan, A., & Rao, P. P. N. (2024) · Current Alzheimer Research · doi:10.2174/0115672050301407240408033046 · Cited by 31 · see citing works

Understanding Alzheimer's disease by global quantification of protein phosphorylation and sialylated N-linked glycosylation profiles: A chance for new biomarkers in neuroproteomics?

Lassen, P. S., Thygesen, C., Larsen, M. R., & Kempf, S. J. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2017.04.003 · Cited by 26 · see citing works

Analysis of post-translational modifications in Alzheimer's disease by mass spectrometry

Kelley, A. R., Bach, S. B. H., & Perry, G. L. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.11.002 · Cited by 25 · see citing works

DNA damage response and repair pathway modulation by non-histone protein methylation: implications in neurodegeneration

Urulangodi, M., & Mohanty, A. (2019) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-019-00538-2 · Cited by 21 · see citing works

Protein modification in neurodegenerative diseases

Ramazi, S., Dadzadi, M., Darvazi, M., Seddigh, N., & Allahverdi, A. (2024) · MedComm · doi:10.1002/mco2.674 · Cited by 24 · see citing works

The Emerging Role of Proteomics in Precision Medicine: Applications in Neurodegenerative Diseases and Neurotrauma

Alaaeddine, R. A., Fayad, M., Nehme, E., Bahmad, H. F., & Kobeissy, F. H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-60733-7_4 · Cited by 20 · see citing works

Tau Is Truncated in Five Regions of the Normal Adult Human Brain

Friedrich, M. G., Skora, A. S., Hancock, S. E., Mitchell, T. W., Else, P. L., & Truscott, R. J. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073521 · Cited by 21 · see citing works

Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation

Didonna, A., Cantó, E., Shams, H., Isobe, N., Zhao, C., Caillier, S. J., Condello, C., Yamate-Morgan, H., Tiwari-Woodruff, S. K., Mofrad, M. R. K., et al. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.04.003 · Cited by 19 · see citing works

Sunset yellow degradation product, as an efficient water-soluble inducer, accelerates 1N4R Tau amyloid oligomerization: In vitro preliminary evidence against the food colorant safety in terms of “Triggered Amyloid Aggregation”

Ojaghi, S., Mohammadi, S., Amani, M., Ghobadi, S., Bijari, N., Esmaeili, S., & Khodarahmi‬, R. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104123 · Cited by 18 · see citing works

Mitochondrial One-Carbon Metabolism and Alzheimer’s Disease

Yu, Y., & Martins, L. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126302 · Cited by 17 · see citing works

Mass Spectrometry Analysis of Lysine Posttranslational Modifications of Tau Protein from Alzheimer’s Disease Brain

Thomas, S. N., & Yang, A. J. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6598-4_10 · Cited by 15 · see citing works

Regulation of Tau Homeostasis and Toxicity by Acetylation

Tracy, T. E., Claiborn, K. C., & Gan, L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_4 · Cited by 16 · see citing works

Tau Protein Biosensors in the Diagnosis of Neurodegenerative Diseases

Sadeghzadeh, J., Shahabi, P., Farhoudi, M., Kalan, A. E., Mobed, A., & Shahpasand, K. (2022) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2023.061 · Cited by 15 · see citing works

The Involvement of Post-Translational Modifications in Regulating the Development and Progression of Alzheimer’s Disease

Guan, P.-P., & Wang, P. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03277-z · Cited by 15 · see citing works

The tau oligomer antibody APNmAb005 detects early-stage pathological tau enriched at synapses and rescues neuronal loss in long-term treatmentsPreprint

Tai, H., Ma, H.-T., Huang, S.-C., Wu, M., Wu, C., Lai, Y., Li, Z., Margolin, R. A., Intorcia, A. J., Serrano, G. E., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.24.497452 · Cited by 15 · see citing works

Tau mRNA Metabolism in Neurodegenerative Diseases: A Tangle Journey

da Costa, P. J., Hamdane, M., Buée, L., & Martin, F. (2022) · Biomedicines · doi:10.3390/biomedicines10020241 · Cited by 14 · see citing works

Roles of Lysine Methylation in Glucose and Lipid Metabolism: Functions, Regulatory Mechanisms, and Therapeutic Implications

Wang, Z., & Liu, H. (2024) · Biomolecules · doi:10.3390/biom14070862 · Cited by 14 · see citing works

Aging-Related Tau Astrogliopathy in Aging and Neurodegeneration

McCann, H., Durand, B., & Shepherd, C. E. (2021) · Brain Sciences · doi:10.3390/brainsci11070927 · Cited by 14 · see citing works

The hidden players: Shedding light on the significance of post-translational modifications and miRNAs in Alzheimer's disease development

Singh, R. J., Hussain, J., Kaur, A., Jamdare, B. G., Pathak, D., Garg, K., Kaur, R., Shankar, S., & Sunkaria, A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102002 · Cited by 13 · see citing works

Recent advances in applying mass spectrometry and systems biology to determine brain dynamics

Scifo, E., Calza, G., Fuhrmann, M., Soliymani, R., Baumann, M., & Lalowski, M. M. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1335200 · Cited by 13 · see citing works

Detection, visualization and quantification of protein complexes in human Alzheimer’s disease brains using proximity ligation assay

Romero‐Fernandez, W., Carvajal‐Tapia, C., Prusky, A., Katdare, K. A., Wang, E., Shostak, A., Ventura‐Antunes, L., Harmsen, H. J., Lippmann, E. S., Fuxé, K., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-38000-4 · Cited by 11 · see citing works

Acetylated tau exacerbates apoptosis by disturbing mitochondrial dynamics in HEK293 cells

Zhang, J., Fang, Z., Zhao, J., Liu, G., Shen, X., Jiang, G., & Liu, Q. R. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16053 · Cited by 11 · see citing works

Tau Lysine Pseudomethylation Regulates Microtubule Binding and Enhances Prion-like Tau Aggregation

Xia, Y., Bell, B. M., & Giasson, B. I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098286 · Cited by 10 · see citing works

Methylation at a conserved lysine residue modulates tau assembly and cellular functions

Shams, H., Matsunaga, A., Ma, Q., Mofrad, M. R. K., & Didonna, A. (2022) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2022.103707 · Cited by 10 · see citing works

Decoding tau acetylation in Alzheimer’s disease and tauopathies: from site-specific mechanisms to therapeutic horizons

Oh, Y. R., & Shin, M. (2025) · BMB Reports · doi:10.5483/bmbrep.2025-0077 · Cited by 9 · see citing works

Tau post-translational modifications in Alzheimer's disease: Insights into pathogenesis, therapeutic strategies, and diagnostic advances

Lei, H., Chen, X., Ruan, L., Liu, X., Ye, F., Li, K., Cheng, W., Yu, B., Di, C., & Di, C. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102927 · Cited by 7 · see citing works

Tau protein: Physiological functions and multifaceted roles in neurodegenerative and psychiatric disorders

Tang, F., Wei, J., Wong, M.-L., & Lei, P. (2025) · Genomic psychiatry : · doi:10.61373/gp025i.0122 · Cited by 7 · see citing works

Progress in Analysis of Tau Protein

Li, L., & Wang, X. (2020) · Chinese Journal of Analytical Chemistry · doi:10.1016/s1872-2040(20)60024-x · Cited by 7 · see citing works

DL‐3‐n‐butylphthalide‐induced neuroprotection in rat models of asphyxia‐induced cardiac arrest followed by cardiopulmonary resuscitation

Yang, S. T., Yu, C., Yang, Z., Cui, H. Z., Wu, Y., Liang, Z., Liu, Y., Shi, X. Q., Shao, F., Zhao, S., et al. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30442 · Cited by 7 · see citing works

Acetylation Mimetic and Null Mutations Within the Filament Core of P301L Tau Have Varied Effects on Susceptibility to Seeding and Aggregation

Smith, E. D., Torrellas, J., McKenna, R., Vo, Q., Mietzsch, M., Borchelt, D., Prokop, S., & Chakrabarty, P. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70221 · Cited by 6 · see citing works

CHAS, a deconvolution tool, infers cell type-specific signatures in bulk brain histone acetylation studies of neurological and psychiatric disordersPreprint

Murphy, K. B., Ye, Y., Tsalenchuk, M., Nott, A., & Marzi, S. J. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.06.459142 · Cited by 6 · see citing works

Advances in Alzheimer’s disease: mechanistic insights and therapeutic targets

Jia, Y.-J., Ge, Y., Li, B., Yang, Y., Chen, H., Liu, J., Guo, J., Yu, J., Ye, K., Wang, J., et al. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-2991-7 · Cited by 5 · see citing works

Making tau amyloid models in vitro: a crucial and underestimated challenge

Broc, J., Piersson, C., & Fichou, Y. (2025) · FEBS Letters · doi:10.1002/1873-3468.70022 · Cited by 5 · see citing works

Implications of Mucin-Type O-Glycosylation in Alzheimer’s Disease

Navarro, N. V., Mundim, G. D. N., & Čudić, M. (2025) · Molecules · doi:10.3390/molecules30091895 · Cited by 5 · see citing works

Identification of a reciprocal negative feedback loop between tau-modifying proteins MARK2 kinase and CBP acetyltransferase

Tabassum, Z., Tseng, J., Isemann, C., Tian, X., Chen, Y., Herring, L. E., & Cohen, T. J. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101977 · Cited by 5 · see citing works

Molecular Mechanism of Tau Misfolding and Aggregation: Insights from Molecular Dynamics Simulation

Zhong, H., Liu, H., & Liu, H. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230409145247 · Cited by 5 · see citing works

Targeted tau protein degradation: a promising therapeutic approach for tauopathies

Baazaoui, N., Alfaifi, M. Y., Shati, A. A., Saad, R. B., & Garzoli, S. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.11.041 · Cited by 4 · see citing works

Tungsten disulphide nanosheet modulated fluorescent gold nanocluster immunoprobe for the detection of tau peptide: Alzheimer's disease biomarker

Abraham, M. K., Madanan, A. S., Varghese, S., Shkhair, A. I., Indongo, G., Rajeevan, G., Kala, A. B. K., & George, S. (2024) · Analytical Methods · doi:10.1039/d4ay02014f · Cited by 4 · see citing works

A liquid chromatography tandem mass spectroscopy approach for quantification of protein methylation stoichiometry

Cooper, G. L., Huseby, C. J., Chandler, C. N., Cocuron, J., Alonso, A. P., & Kuret, J. (2018) · Analytical Biochemistry · doi:10.1016/j.ab.2018.01.018 · Cited by 4 · see citing works

Post‐translational modification sites are present in hydrophilic cavities of alpha‐synuclein, tau, FUS , and TDP ‐43 fibrils: A molecular dynamics study

Kochen, N. N., Seaney, D., Vasandani, V., Murray, M., Braun, A. R., & Sachs, J. N. (2024) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26679 · Cited by 4 · see citing works

Minimotifs dysfunction is pervasive in neurodegenerative disorders

Sharma, S., Young, R. J., Chen, J., Chen, X., Oh, E. C. T., & Schiller, M. R. (2018) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.06.005 · Cited by 4 · see citing works

Mass Spectrometry Analysis of Lysine Posttranslational Modifications of Tau Protein from Alzheimer’s Disease Brain

Thomas, S. N., & Yang, A. J. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6598-4_10 · Cited by 15 · see citing works

Lysine-Directed Post-translational Modifications of Tau Protein in Alzheimer's Disease and Related Tauopathies

Kontaxi, C., Piccardo, P., & Gill, A. C. (2017) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2017.00056 · Cited by 138 · see citing works

Quantification of Tau Protein Lysine Methylation in Aging and Alzheimer’s Disease

Huseby, C. J., Hoffman, C. N., Cooper, G. L., Cocuron, J.-C., Alonso, A. P., Thomas, S. N., Yang, A. J., & Kuret, J. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190604 · Cited by 54 · see citing works

Lysine methylation is an endogenous post-translational modification of tau protein in human brain and a modulator of aggregation propensity

Funk, K. E., Thomas, S. N., Schafer, K. N., Cooper, G. L., Liao, Z., Clark, D. J., Yang, A. J., & Kuret, J. (2014) · Biochemical Journal · doi:10.1042/bj20140372 · Cited by 142 · see citing works

SETD7-mediated monomethylation is enriched on soluble Tau in Alzheimer’s disease

Bichmann, M., Oriol, N. P., Ercan-Herbst, E., Schöndorf, D. C., Ramos, B. G., Schwärzler, V., Neu, M., Schlüter, A., Wang, X. B., Jin, L., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00468-x · Cited by 31 · see citing works